Navigation Links
Biomarker May Signal HIV Progression
Date:3/28/2008

Increase in specific white blood cells could warn doctors early to change treatments

FRIDAY, March 28 (HealthDay News) -- Researchers at Temple University think they may have found a blood marker that denotes the progression of the virus that causes AIDS.

The researchers found an increase in the CD163+/CD16+ monocyte subset may coincide with the advancement of human immunodeficiency virus (HIV), according to a study published in the March issue of AIDS Research and Human Retroviruses.

"It looks like, based on these correlations, that this particular cell type may be involved in immune impairment and the progression of HIV," Jay Rappaport, a professor of neuroscience and neurovirology who oversaw the study, said in a prepared statement. "Is it a good prognostic indicator? If you have a lot of these monocytes, does it mean you are going to progress into AIDS faster? Right now, all we know is what the correlations are."

A monocyte is a specific white blood cell, a part of the human body's immune system that protects against blood-borne pathogens and moves quickly to sites of infection within the body's tissues. As monocytes enter tissue, they undergo a series of changes.

The researchers investigated these alterations by examining 18 patients with HIV and seven individuals without HIV.

"We did, indeed, find that patients with detectable virus had an increase of this monocyte subset that correlated with the amount of virus they had in their blood," study author Tracy Fischer-Smith, an associate scientist in Temple's Neuroscience Department, said in a prepared statement. "We were surprised to find that in patients with CD4+ T-cell counts of less than 450 cells per microliter [200 or less per microliter is defined as AIDS], the increase of this monocyte subset correlates inversely with the number of T-cells."

Fischer-Smith said this finding suggests that as the monocyte cells are in
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Expansion of monocyte subset could serve as a biomarker for HIV progressions
2. Biomarkers and Innovation Push Global Cancer Diagnostics Market Toward $8 Billion
3. Biomarkers for Mood May Alter Psychiatric Treatments
4. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
5. Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer
6. New developments in biomarkers for epithelial ovarian cancer
7. Biomarkers for Alzheimers disease can be trusted in clinical trials
8. JDRF and Lilly partner to fund research to identify beta cell biomarkers
9. Biomarkers predict risk for invasive breast cancer years before the tumor develops
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Biomarker may be an early predictor of advanced breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... wheezing, study finds , , TUESDAY, Nov.... traffic pollution and indoor endotoxin are at inc...toxin -- a component of bacteria believed to trigg...t. , University of Cincinnati College of Medici... warning sign of asthma and other lung conditions)...
(Date:11/24/2009)...g that testing less is OK , , TUESDAY, N...eening has been upended in the past two weeks. ,...orce (USPSTF) just raise the age at which it recom...0, but the American College of Obstetrics and Gyne...e spared the inconvenience and possible risks of c...
(Date:11/24/2009)...ire-FirstCall/--ICL(TASE:ICL),a,multinationalferti...sultsforthethirdquarterandninemonthsendedSeptember... , Revenues:Revenuesforthethirdquarterof2009w...1,083millionforthesecondquarterof,2009.Revenuesfor...theexceptionaldemandandpricesthatcharacterizedthat...
(Date:11/24/2009)...rkets build on their combined strength and momentu... Baltimore, Md. (PRWEB) November 24, 20...private equity firm based in Baltimore, Maryland, ...p.com ), a venture capital firm based in College P...ired Ecoast Sales Solutions, Ltd. ("eCoast&qu...
(Date:11/24/2009)...ld Volunteer Computing Team has joined the QMC@hom...Carlo method to problems in Quantum Chemistry. The...e science research. This project joins Folding@hom...vity wave detection), and GPUGrid (molecular biol... (PRWEB) November 24, 2009 -- GeoPense ...
Breaking Medicine News(10 mins):Health News:Traffic, Dust Linked to Asthma in Kids 2Health News:Recent Cancer Screening Changes Leave Many Confused 2Health News:Recent Cancer Screening Changes Leave Many Confused 3Health News:Recent Cancer Screening Changes Leave Many Confused 4Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 2Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 3Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 4Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 5Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 6Health News:ICL Reports Continued Sequential Improvement for Third Quarter of 2009 7Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 2Health News:Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 3Health News:GeoPense Announces it has Joined QMC@home Project 2
...Health Museum in Houston, Texas to be Site of Fac... May 30, 2009, the John P. McGovern Museum of Heal...useum, will launch the U.S. premiere of Facing Ma...d consider the implications humans face in their q...
... With the recent news that one in three ...thy lifestyle is more important than ever. Texans ...festyles than during busier times of the year. Tex...PRWEB) May 27, 2009 -- With the release of a recen...
...., May 27 , , Core News Facts : , , ...ty to interact with care providers online are lead...tients are taking a consumerist approach in choosi...gh American Recovery and Reinvestment Act for "mea...
...rned of side effect that could hamper immigration ...ws) -- The widely used cancer drug capecitabine ca...ould lead to problems when they,re trying to enter...he now advises people taking capecitabine to carry...
...ed at the Canadian-run military hospital in Kandah...vilian disasters, according to a London, Ontario p... Dr. Vivian McAlister is a professor in the Depar...es Centre. He spent two months working at the Kand...
...AGE, Colo., May 27 Recondo Technology, a leading ... care industry, today announced the firm,s selec...designating Recondo as one of the top 100 companie...newscom.com/cgi-bin/prnh/20090325/LA89162LOGO ) , ...
Other Medicine News:Health News:If You Could Travel to Mars, Would You Go? 2Health News:If You Could Travel to Mars, Would You Go? 3Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 2Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 3Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 4Health News:Fighting Preventable Cancers: Texas Oncology Encourages a Healthy Summer Lifestyle 5Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 2Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 3Health News:Greenway Medical Technologies' PrimePatient Solution Transforms Physician/Patient Relationship Through Enhanced Communication Channels and Improved Workflows 4Health News:Fingerprints May Vanish With Cancer Drug 2Health News:Sharing surgical lessons from the Canadian field hospital in Afghanistan 2Health News:Recondo Technology Wins Red Herring 100 North America Award 2
(Date:11/24/2009)...ire/--MAQUETCardiovascularLLC,aleadingproviderofca...gnedaguaranteedtwo-yearcontractwithNovation,oneoft...thesolesourceproviderofsurgicaldevicesforbeatinghe...nt,whichrunsthroughOctober31,2012,MAQUETCardiovasc...sanddisposablesuppliestothemembersofVHAInc.andUniv...
(Date:11/24/2009)...wire-FirstCall/--ZimmerHoldings,Inc.(NYSE: ZMH ;SI...AnnualPiperJaffrayHealthCareConferenceinNewYork,Ne..., AlivewebcastofthepresentationcanbeaccessedviaZim...mmer.com .Thewebcastwillbearchivedforreplayfollowi...ndedin1927andheadquarteredinWarsaw,Indiana,Zimmerd...
(Date:11/24/2009)...4/PRNewswire/--SatelliteHealthcare,oneofthenation,...ndamajorsponsorofnephrologyresearch,todayannounced...srallahinhisefforttosupporttheSanJosehomelessthisT...essfulcareerasachefforthepast20years.ButNasrallah,...gnosedwithEndStageRenalDisease(ESRD).Thediagnosisi...
Breaking Medicine Technology:MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Country United symposium explores collaborative future of military medicine 58428 1Country United symposium explores collaborative future of military medicine 58428 2Country United symposium explores collaborative future of military medicine 58428 3Orgasms sexual health and attitudes about female genitals 58425 1Orgasms sexual health and attitudes about female genitals 58425 2Global public health the focus of scientific conference 10144 1Global public health the focus of scientific conference 10144 2
...b Trial to Examine Safety and Efficacy of DARA ver...rmacopeia,(Nasdaq: PCOP ), an innovator in the di...erapeutics, today announced the initiation of a Ph...ead internal product candidate.,This randomized, d...l-group study is designed to evaluate the compound...
...LE, Md., Feb. 29 A study reported in,the journal ... in the,Ciliary Neurotrophic Factor gene (CNTF) ma...study, conducted by Vanda Pharmaceuticals,Inc., in...ia who were,treated either with Fiapta(TM) (iloper...ntly under review with the FDA, or placebo.,Patien...
Other Medicine Technology:Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA) 4Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 2Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 3
ScanGel® Incubator
... up to 12 mini gels under identical conditions in ... a time with the new Model 485 gradient former and... sources of variation and improving reproducibilit... convenience and reproducibility demanded by highe...
... up to 12 mini gels under identical conditions in ... a time with the new Model 485 gradient former and... sources of variation and improving reproducibilit... convenience and reproducibility demanded by highe...
...is system mirrors a 96-well plate in format, allow...ducts to take place easily and with direct compati...be carried out directly with a multi-channel pipet... off-set marker lanes are also included (one on ea...
Medicine Products: